Celaid Therapeutics
Change the future with cell therapy
- Headquarters
- Tokyo
- Employees
- 1–10
- Business Model
- B2B
- Website
- celaidtx.com
About
Celaid Therapeutics is a Japan-based biotechnology company, born out of the University of Tokyo and University of Tsukuba, that has developed a proprietary platform technology for the efficient ex vivo expansion of human hematopoietic stem cells (HSCs). The company's technology enables mass propagation of functional HSCs without animal-derived components, producing high-quality cells at low cost for use in next-generation transplantation, gene therapy, and treatments for leukemia, other hematologic cancers, and genetic disorders. Celaid raised a ¥1.055 billion (USD $7.2 million) Series B first close in October 2025 to advance its lead program CLD-001 through clinical development.
Summary
Celaid Therapeutics is a Biotech company based in Tokyo, Japan.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/celaid-therapeutics"><img src="https://indexed.vc/api/badge/company/celaid-therapeutics" alt="Celaid Therapeutics on Indexed.vc" width="260" height="76" /></a>